Consensus conference on foam sclerotherapy at the 2nd International European Symposium on Sclerotherapy (April 4-6, 2003, Tegernsee, Germany);Konsensuskonferenz zur schaumsklerotherapie: Anlässlich des 2. Internationalen Europäischen Symposiums über Sklerotherapie (4.-6. April 2003, Tegernsee)

Phlebologie

Volumn 33, Issue 3, 2004, Pages 97-105

  Breu, Franz Xaver ^a   Guggenbichler, St ^a   Marshall, M ^a  

^a NONE   (Germany)

Author keywords

Foam sclerotherapy

Indexed keywords

CONFERENCE PAPER; CONTINUING EDUCATION; FOAM; INTERMETHOD COMPARISON; QUESTIONNAIRE; SCLEROTHERAPY; TREATMENT OUTCOME; VARICOSIS;

EID: 3042764184     PISSN: 0939978X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1617280     Document Type: Conference Paper

References (48)

1. Allegra C, Antignani P-L, Bergan JJ et al. The »C« of CEAP: suggested definitions and refinements: an international union of phlebology conference of experts. J Vasc Surg 2003; 37: 129-31.
2. Baccaglini U, Spreafico G, Castoro C et al. Consensus conference on sclerotherapy or varicose veins of the lower limbs. Phlebology 1997; 12: 2-16.
3. Beebe HG, Bergan JJ, Bergqvist D et al. Classification and grading of chronic venous disease in the lower limbs - A consensus statement. VASA 1995; 24: 313-8.
4. Belcaro G, Cesarone M, Nicolaides A et al. Comparison among treatment schemes for varicose veins: surgery, sclerotherapy, foam-sclerotherapy and combined options. In: Belcaro G, Geroulakos G, Cesarone M et al. (eds). Sclerotherapy in venous disease. Torino: Edizioni Minerva Medica 2003; 95-103.
5. Belcaro G, Cesarone M, Nicolaides A et al. Micro-sclerotherapy. In: Belcaro G, Geroulakos G, Cesarone M et al. (eds). Sclerotherapy in venous disease. Torino: Edizioni Minerva Medica 2003; 89-93.
6. Benigni JP, Sadoun S et al. Télangiectasies et varices réticulaires - Traitement par la mousse d'Aetoxisclérol à 0.25% - Présentation d'une étude pilote. Phlébologie 1999; 52: 283-90.
7. Benigni JP. Polidocanol 400 foam injection and migraine with visual aura. American College of Phlebology. 16th Annual Congress. Ft. Lauderdale, Florida, 2002; 139.
8. Bhowmick A, Harper D, Wright D et al. Polidocanol microfoam sclerotherapy for long saphenous varicose veins. Phlebology 2001; 16: 41-50.
9. Breu FX, Marschall M. Sklerotherapie. In: Marschall M, Breu FX (Hrsg). Handbuch der Angiologie. Landsberg: Ecomed 2003; III-6.3.
10. Cabrera J, Cabrera Garcia-Olmedo. Nuevo método de esclerosis en las varices tronculares. Patologia Vascular 1995; 4: 55-37.
11. Cabrera J. Application techniques for sclerosant in microfoam form. In: Henriet JP (ed). Foam sclerotherapy state of the art. Paris: Editions Phlebologiques Françaises 2002; 39-44.
12. Cavezzi A, Frullini A, Ricci S et al. Treatment of varicose veins by foam sclerotherapy: Two clinical series. Phlebology 2002; 17: 13-8.
13. Fegan WG. Varicose veins: compression sclerotherapy. London: Heinemann Medical Books 1967.
14. Flückiger P. Nicht-operative retrograde Varicenverödung mit Varsylschaum. Schweiz Med Wochenschr 1956; 48: 1368-70.
15. Frullini A. New technique in producing sclerosing foam in a disposable syringe. Dermatol Surg 2000; 26: 705-6.
16. Frullini A. Sclerosing foam in the treatment of recurrent varicose veins. In: Henriet JP (ed). Foam sclerotherapy state of the art. Paris: Editions Phlebologiques Françaises 2002; 73-8.
17. Frullini A. The sclerosing foam in the treatment of teleangectasia and varicose veins: new techniques for production of a foam with sterile air. American College of Phlebology. 14th Annual Congress, Atlanta, Georgia, 2000; 246.
18. Gachet G. Une nouvelle méthode simple et économique pour confectionner de la mousse pour sclérose échoguidée. Phlébologie 2001; 54: 63-5.
19. Garcia-Mingo J. "Foam medical system": a new technique to treat varicose veins with foam. In: Henriet JP (ed). Foam sclerotherapy state of the art. Paris: Editions Phlebologiques Francaises, 2002; 45-50.
20. Hamel-Desnos C, Desnos P et al. Nouveautés thérapeutiques dans la prise en charge de la maladie variqueuse: écho- sclérothérapie et mousse. Phlébologie 2003; 56: 41-8.
21. Hamel-Desnos C, Desnos P, Wollmann JC et al. Evaluation of the efficacy of polidocanol in form of foam compared to liquid form in sclerotherapy of the long saphenous vein. Dermatol Surg 2003; 29: 1170-5.
22. Hamel-Desnos C, Ouvry P, Desnos P et al. Evaluation of the efficacy of polidocanol in the form of foam versus liquid form in sclerotherapy of the long saphenous vein. American College of Phlebology 16th Annual Congress, Ft. Lauderdale, Florida, 2002; 246.
23. Henriet JP. Expérience durant trois années de la mousse de Polidocanol dans le traitement des varices réticulaires et des varicosités. Phlébologie 1999; 52: 277-82.
24. Kern P. Sclerotherapy of varicose leg veins. Technique, indications and complications. Int Angiol 2002; 21 (Suppl 1): 40-5.
25. Linser P. Über die konservative Behandlung der Varicen. Med Klin 1916; 12: 897-8.
26. Mayer H, Brücke H. Angiologie - Zur Ätiologie und Behandlung der Varizen der unteren Extremitäten. Chir Prax 1957; 1: 521-8.
27. McCollum C, Bhowmick A, Harper D. UK experience with Varisolve Polidocanol microfoam. Int Angiol 2001; 20 (Suppl 1): 86.
28. Monfreux A. Traitement sclérosant des troncs saphéniens et leurs collatérales de gros calibre par la méthode mus. Phlébologie 1997; 50: 351-3.
29. Orbach EJ. Sclerotherapy of varicose veins - utilization of an intravenous air block. Am J Surg 1944; LXVI: 362-6.
30. Ouvry P, Barrellier MT, Escalard JM et al. Sclerotherapy of the long saphenous vein with foam of Lauromacrogol. A prospective duplex controlled randomized study. Protocol and first results. Int Angiol 2001; 20 (Suppl 1): 344.
31. Partsch H, Baccaglini U, Stemmer R. Questionnaire regarding the practice of sclerotherapy. Phlebology 1997; 12: 43-55.
32. Rabe E, Pannier-Fischer F, Gerlach H et al. Leitlinien zur Verödungsbehandlung der Varikose (ICD 10: I83.0, I83.1, I83.2, I83.9) Entwicklungsstufe 1. Phlebologie 2003; 32: 101-6.
33. Rabe E, Pannier-Fischer F, Rabe H. Eponyme in der Phlebologie. Biographien und Begriffe. Köln: Viavital 2002: 9-20.
34. Santos Gaston M. In: Santos Gaston M, Santos-Gaston Orus M (eds). Esclerotherapia de varices. Madrid: Vegaleón 1999; 73-7.
35. Schadeck M, Allaert FA. Duplex scanning in the mechanism of the sclerotherapy: importance of the spasm. Phlebology 1995 (Suppl 1): 574-6.
36. Schadeck M: Duplex-kontrollierte Sklerosierungsbehandlung der Vena saphena magna. Phlebologie 1996; 25: 78-82.
37. Seydewitz V, Staubesand J. Das ultrastrukturelle Substrat der Wirkung paravasal und intraarteriell applizierter Sklerosierungsmittel: Ein experimenteller Beitrag zum Problem iatrogener Schäden nach Sklerotherapie. In: Staubesand J, Schöpf E (Hrsg). Neuere Aspekte der Sklerosierungstherapie. Heidelberg: Springer 1990; 40-65.
38. Sigg K. Neuere Gesichtspunkte zur Technik der Varizenbehandlung. Ther Umsch Med Bibliographie 1949; 6: 127-34.
39. Sigg K. Varizen, Ulcus cruris und Thrombose. Berlin: Springer 1976.
40. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001; 27: 58-60.
41. Tessari L. Extemporary sclerosing foam according to personal method: Experimental clinical data and catheter usage. Int Angiol 2001; 20 (Suppl 1): 54.
42. Tessari L. Nouvelle technique d'obtention de la scléro-mousse. Phlébologie 2000; 53: 129.
43. Tournay R. La sclérose des varices. Paris: Expansion Scientifique Francaise 1985.
44. Wollmann JC. An experimental model to pinpoint properties and behavior of sclerosing foams. American College of Phlebology 17th Annual Congress, San Diego, California, August 27-31, 2003.
45. Wollmann JC. Schaum - zwischen Vergangenheit und Zukunft. 8. Bonner Venentage 15.-16. Feb. 2002. Vasomed 2002; 16: 34-5.
46. Wollmann JC. The history of sclerosing foams. Dermatol Surg 2004 (in press) DS-00474-2003.
47. Yamaki T, Nozaki M, Fujiwara O et al. Duplex-guided foam sclerotherapy for the treatment of the symptomatic venous malformations of the face. Dermatol Surg 2002; 28: 619-22.
48. Yamaki T, Nozaki M, Sasaki K. Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 2000; 26: 323-8.